Cargando…

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study

BACKGROUND AND AIM: Long‐term human albumin (HA) infusions improve survival in cirrhotic patients with diuretic resistant ascites. We aimed to determine whether there is a significant benefit in a more unwell real‐world cohort. METHODS: This is a single‐center retrospective cohort study. Patients re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hannah, Nicholas, Tjandra, Douglas, Patwardhan, Ashwin, Rutland, Kelsey, Halliday, John, Sood, Siddharth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463019/ https://www.ncbi.nlm.nih.gov/pubmed/37649856 http://dx.doi.org/10.1002/jgh3.12944

Ejemplares similares

Long-term albumin infusion in decompensated cirrhosis: A review of current literature
por: Wong, Yu Jun, et al.
Publicado: (2021)

Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2019)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Effective albumin – A novel paradigm in the management of decompensated liver cirrhosis
por: Bernardi, Mauro
Publicado: (2023)

Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023)

The Association Between Decompensated Liver Cirrhosis and Deep Neck Infection: Real-World Evidence
por: Tsai, Ming-Shao, et al.
Publicado: (2019)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2020)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis
por: Han, Zhong, et al.
Publicado: (2021)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis
por: Oyelade, Tope, et al.
Publicado: (2023)

Use of albumin infusion for cirrhosis-related complications: An international position statement
por: Bai, Zhaohui, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Efficacy and Safety of Immunosuppressive Therapy for PBC–AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study
por: Fan, Xiaoli, et al.
Publicado: (2018)

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
por: Ji, Fanpu, et al.
Publicado: (2017)

Tense Ascites in Cirrhosis: Paracentesis With Albumin Infusion Versus Spontaneous Ascites Filtration
por: Robson, Simon C.
Publicado: (1994)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy
por: Premkumar, Madhumita, et al.
Publicado: (2012)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis
por: Cai, Ming, et al.
Publicado: (2021)

Clostridioides difficile Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
por: Dungan, William, et al.
Publicado: (2022)

Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
por: Liu, Baochi, et al.
Publicado: (2021)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

1625. Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)
por: Van Anglen, Lucinda J, et al.
Publicado: (2020)

D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis
por: Sun, Lin, et al.
Publicado: (2022)

Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023)

Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review
por: O’Connell, Malene Barfod, et al.
Publicado: (2023)

Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis
por: Pusateri, Antoinette, et al.
Publicado: (2023)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qakc5tpfmdm91fas9ouvsb8gk3